Vamorolone FAQs in JM

Vamorolone FAQ

The FDA will soon be ruling on a new drug application for the use of vamorolone in Duchenne muscular dystrophy. We understand that families have questions surrounding vamorolone’s status for use in juvenile myositis. 

We have consulted with JM experts on the potential implications of a pending approval for the drug in another disease and what this currently means for JM patients.

Frequently Asked Questions & Answers

Question 1: What does a potential FDA approval for vamorolone in Duchenne muscular dystrophy mean for JM patients?

Answer: Currently, vamorolone needs to be further studied in JM, with safety and efficacy being primary considerations. Duchenne muscular dystrophy and juvenile dermatomyositis are different diseases and would require separate studies.

Question 2: Is vamorolone currently available to JM patients?

Answer: Currently, vamorolone is not a treatment option in JM. JDM is an autoimmune disease that causes significant inflammation.  We do not yet know if vamorolone would be effective and safe in treating JM and, if so, what dosage of vamorolone would be required.

Question 3: What are the needs or next steps for a similar trial approval in JM?

Answer: Cure JM is working with ReveraGen on the feasibility of a trial in JM.

Question 4: Why is prednisone a first line medication in treating JM?

Answer: Steroids are life-saving medications. Any other questions about steroids or other medications should be discussed with your doctor individually, as each situation and each patient is unique.  

Parrish’s Story

We would like to introduce a one-of-a-kind, competitive, and determined young man, named Parrish. His story of resiliency and hope is one that will resonate with many of us in the Cure JM family. Parrish faced many challenges in his journey with JM, but found hope and support in his family and the Cure JM community. We are pleased to now share his experience to help others facing the same struggles during Myositis Awareness Month.

Balancing Work and Caregiving: Strategies for Working Parents of Children with Juvenile Myositis

Balancing the demands of a career with the responsibilities of caregiving is a challenging task for any parent. For those with a child diagnosed with juvenile myositis (JM), a rare autoimmune disease affecting children, the challenge is heightened. Juggling work commitments while providing the necessary care and support for a child with JM can be taxing. In this article, we hope to provide you with a few effective strategies and insights to help working parents navigate this delicate balance.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.